Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Karima Debbache"'
Autor:
Dehbia Menouche, Lucile Offredo, Anoosha Habibi, Philippe Connes, Karima Debbache, Frédéric Galactéros, Pablo Bartolucci, Jean Louis Beaumont, Amna Jebali, Nassim Ait Abdallah, Brigitte Ranque, Gaetana Di Liberto
Publikováno v:
Vox Sanguinis. 115:722-728
Background Blood transfusion is the cornerstone treatment to reduce the clinical severity of sickle cell disease (SCD), but we need to maintain the haematocrit (Hct) within an acceptable range to avoid a deleterious increase in blood viscosity. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3032b0ba6899c6bc74c8a9436df13b32
https://doi.org/10.1111/vox.12990
https://doi.org/10.1111/vox.12990
Autor:
Karima Debbache, Jean-Antoine Ribeil, Justine Gellen-Dautremer, Marianne Delville, Laurent Sabbah, Sameh Awad, Barnabas Gellen, Sandra Manceau, Vincent Audard, François Lefrère, Nassim Ait Abdallah, Françoise Driss, Jean-Louis Beaumont, Jan Stolba, Cécile Arnaud, Marina Cavazzana, Gilbert Franco, Thibaud Damy, Christelle Chantalat-Auger, Frédéric Galactéros
Publikováno v:
American Journal of Hematology. 92:136-140
Erythrocytapheresis (ER) can improve outcome in patients with sickle cell disease (SCD). A good vascular access is required but frequently it can be difficult to obtain for sickle cell patients. Arterio-venous fistulas (AVFs) have been suggested for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e162eb3e5879f62ba6c88df121d2afb8
https://doi.org/10.1002/ajh.24600
https://doi.org/10.1002/ajh.24600
Publikováno v:
Dermatology and Therapy
Introduction Pentostatin (2′-deoxycoformycin) and cladribine (2-chlorodeoxyadenosine) are adenosine analogues widely used to treat lymphoid malignancies, mainly hairy cell leukemia (HCL). Oral or parenteral adenosine analogues have been also used a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60aa26aa1d5dae35f625cfc2d2f0bc33
https://pubmed.ncbi.nlm.nih.gov/29196889
https://pubmed.ncbi.nlm.nih.gov/29196889
Autor:
Kaiss Lassouedand Bachra Choufi, Tamim Alsuliman, Karima Debbache, Elisabeth Maillot, Maelle Terrom
Publikováno v:
Journal of Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bae3223a7c04ee407fa007c90a056b7
https://doi.org/10.4172/2329-6917.1000237
https://doi.org/10.4172/2329-6917.1000237
Autor:
C. Bachmeyer, C. Blas-Chatelain, Karima Debbache, François Lionnet, Patricia Senet, J.-M. Bureau, K. Stankovic-Stojanovic, Tristan Mirault, Pierre Levy, Robert Girot, C. Baldeschi, J. Gellen-Dautremer, C. Debure, E.M. Manea, M. Peschanski, Frédéric Galactéros
Publikováno v:
The British journal of dermatology. 177(1)
SummaryBackground Leg ulcers (LUs) are a chronic and severe complication of sickle cell disease (SCD). A prospective study in patients with SCD to identify factors associated with complete healing and recurrence of LUs is lacking. Objectives To deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52d2c68a78a8ba0ffa659e4b15d8b1be
https://pubmed.ncbi.nlm.nih.gov/28731246
https://pubmed.ncbi.nlm.nih.gov/28731246
Autor:
Marianne, Delville, Sandra, Manceau, Nassim, Ait Abdallah, Jan, Stolba, Sameh, Awad, Thibaud, Damy, Barnabas, Gellen, Laurent, Sabbah, Karima, Debbache, Vincent, Audard, Jean-Louis, Beaumont, Cécile, Arnaud, Christelle, Chantalat-Auger, Françoise, Driss, François, Lefrère, Marina, Cavazzana, Gilbert, Franco, Frederic, Galacteros, Jean-Antoine, Ribeil, Justine, Gellen-Dautremer
Publikováno v:
American journal of hematology. 92(2)
Erythrocytapheresis (ER) can improve outcome in patients with sickle cell disease (SCD). A good vascular access is required but frequently it can be difficult to obtain for sickle cell patients. Arterio-venous fistulas (AVFs) have been suggested for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2959671363fb1a9c0da5e9d10ea62699
https://pubmed.ncbi.nlm.nih.gov/27813144
https://pubmed.ncbi.nlm.nih.gov/27813144
Publikováno v:
Revue Francophone des Laboratoires. 2007:45-50
Resume Les hemopathies malignes representent la principale indication de l'allogreffe de cellules souches hematopoietiques (CSH) en hematologie. De nombreux progres dans les traitements immunosuppresseurs et les traitements anti-infectieux ont permis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78d088952ae3e64248951e0b44be8abb
https://doi.org/10.1016/s1773-035x(07)80397-2
https://doi.org/10.1016/s1773-035x(07)80397-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marianne Delville, Christelle Chantalat-Auger, Sameh Awad, Barnabas Gellen, Justine Gellen-Dautremer, Thibaud Damy, Sandra Manceau, Laurent Sabbah, Jean-Antoine Ribeil, Karima Debbache, Cécile Arnaud, Jean-Louis Beaumont, Marina Cavazzana, François Lefrère, Nassim Ait Abdallah, Jan Stolba, Françoise Driss, Frédéric Galactéros, Vincent Audard, Gilbert Franco
Publikováno v:
Blood. 128:4856-4856
Introduction Erythracytapheresis (ER) can improve outcome in patients with sickle cell disease (SCD). A good vascular access is required but can be difficult to obtain for sickle cells patients. Arterio-venous fistula (AVF) has been suggested for ER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03c4e97302a45b393b67d19e4cc2121a
https://doi.org/10.1182/blood.v128.22.4856.4856
https://doi.org/10.1182/blood.v128.22.4856.4856
Autor:
Claude C.A. Bernard, Nabih Azar, Ludovic Cabanne, Michelle Rosenzwajg, Aliénor Xhaard, Sébastien Maury, Dominique Bories, François M. Lemoine, Felipe Suarez, Karima Debbache, Françoise Roudot-Thoraval, Catherine Cordonnier, Régis Peffault de Latour, Laetitia Gregoire, Jean-Louis Beaumont, David Klatzmann, Mustapha Cherai, Ambroise Marçais, José L. Cohen, Rabah Redjoul
Publikováno v:
Blood. 122:153-153
Background Donor lymphocyte infusions (DLI) can produce lasting remissions in patients with relapsed chronic myeloid leukemia (CML), but are less effective in non-CML diseases. Chemotherapy-induced lymphodepletion prior to DLI, achieved with cyclopho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::453e8a3dae6954877dd1e43a72bbd0f4
https://doi.org/10.1182/blood.v122.21.153.153
https://doi.org/10.1182/blood.v122.21.153.153